Michelson Diagnostics Ltd. (MDL) news

A major study published in leading cancer journal, The Lancet Oncology1 have ground-breaking findings on Michelson Diagnostics, the UK based medical device company that use multi-beam Optical Coherence Tomography (‘OCT’) technology, which can transform patient’s treatment and care of basal cell carcinomas (BCC). It was concluded that OCT-guided diagnosis, when compared to a standard punch biopsy could reduce the number of consultations and invasive procedures by a massive 66

AI specialists Manchester Imaging Ltd have won a UK Innovation Scholars grant to support the parttime secondment of AI expert Tom Williams to skin scanner specialists Michelson Diagnostics Ltd over two years.

Tom is working with Michelson to develop AI software that will process images of basal cell carcinoma, the most common form of skin cancer affecting millions worldwide, scanned by dermatologists using the innovative VivoSight™ OCT scanner already manufactured by Michelson D

Michelson Diagnostics Ltd, manufacturer of the world-leading VivoSight OCT skin imaging and measurement system, has teamed up with AI specialists Manchester Imaging Ltd, to aid dermatologists in the fight against skin cancer and other skin diseases.

Michelson’s VivoSight Dx OCT scanner is used by trained dermatologists in their assessment of suspicious skin lesions, and is already in widespread routine use in Germany for Basal Cell Carcinoma, the most common type of skin cancer.